Study Group |
MR in Drug Research |
Chair: Patricia E. Cole,
M.D., Ph.D., Eisai Pharmaceuticals, Teaneck, NJ, USA |
|
Topics: Academic-Industry
Partnerships in Applications of MRI to Clinical Drug
Development |
|
Monday, 20 April 2009 |
18:30 - 20:30 |
Room 312 |
|
|
Overview: Matching MRI
Applications to Goals of Drug Development |
Perry Renshaw, M.D., Ph.D.,
University of Utah, UT, USA |
|
Finding Value for MRI in
Supporting a Drug Pipeline: a View from Industry |
Rexford Newbould, Ph.D.,
GlaxoSmithKline Clinical Imaging Centre, London, UK |
|
Analysis Tools for
Quantitative MRI Supporting Clinical Applications
|
Stephen M. Smith, D.Phil.,
Centre for Functional Magnetic Resonance Imaging,
University of Oxford, Oxford, UK
|
|
Practical Considerations
for an Academic Laboratory Working to Support Pharma
Industry Projects: Demystifying Some of the "Unknown
Unknowns" |
Nicola De Stefano, M.D.,
Ph.D., University of Siena, Siena, Italy |
|
|
|